These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20632362)

  • 1. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
    Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
    ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
    Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
    ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
    Woo LW; Jackson T; Putey A; Cozier G; Leonard P; Acharya KR; Chander SK; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2010 Mar; 53(5):2155-70. PubMed ID: 20148564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual aromatase-steroid sulfatase inhibitors.
    Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
    Wood PM; Woo LW; Thomas MP; Mahon MF; Purohit A; Potter BV
    ChemMedChem; 2011 Aug; 6(8):1423-38. PubMed ID: 21608133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
    Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
    Jackson T; Woo LW; Trusselle MN; Chander SK; Purohit A; Reed MJ; Potter BV
    Org Biomol Chem; 2007 Sep; 5(18):2940-52. PubMed ID: 17728860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
    Wang M; Mickens J; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
    Steroids; 2009 Nov; 74(12):896-905. PubMed ID: 19559719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors.
    Lloyd MD; Thiyagarajan N; Ho YT; Woo LW; Sutcliffe OB; Purohit A; Reed MJ; Acharya KR; Potter BV
    Biochemistry; 2005 May; 44(18):6858-66. PubMed ID: 15865431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.
    Woo LW; Wood PM; Bubert C; Thomas MP; Purohit A; Potter BV
    ChemMedChem; 2013 May; 8(5):779-99. PubMed ID: 23495205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
    Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity.
    Wood PM; Woo LW; Humphreys A; Chander SK; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):123-30. PubMed ID: 15862957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
    Leese MP; Leblond B; Smith A; Newman SP; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2006 Dec; 49(26):7683-96. PubMed ID: 17181151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
    Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
    Jackson T; Woo LW; Trusselle MN; Chander SK; Purohit A; Reed MJ; Potter BV
    Org Biomol Chem; 2007 Oct; 5(20):2940-52. PubMed ID: 17972413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
    Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
    J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of steroid sulfatase inhibitors.
    Woo LW; Purohit A; Potter BV
    Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First dual aromatase-steroid sulfatase inhibitors.
    Woo LW; Sutcliffe OB; Bubert C; Grasso A; Chander SK; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2003 Jul; 46(15):3193-6. PubMed ID: 12852749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
    Leese MP; Hejaz HA; Mahon MF; Newman SP; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2005 Aug; 48(16):5243-56. PubMed ID: 16078843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
    Walter G; Liebl R; von Angerer E
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.